Quest Diagnostics Return on Investment 2010-2024 | DGX

Current and historical return on investment (ROI) values for Quest Diagnostics (DGX) over the last 10 years.
Quest Diagnostics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-03-31 $1.26B $10.27B 12.12%
2023-12-31 $1.26B $10.75B 12.23%
2023-09-30 $1.13B $10.41B 11.18%
2023-06-30 $1.18B $10.06B 11.72%
2023-03-31 $1.22B $10.06B 12.00%
2022-12-31 $1.43B $9.91B 13.93%
2022-09-30 $1.83B $10.25B 17.60%
2022-06-30 $2.09B $10.43B 20.01%
2022-03-31 $2.23B $10.40B 21.65%
2021-12-31 $2.38B $10.49B 22.85%
2021-09-30 $2.64B $10.44B 25.14%
2021-06-30 $2.71B $9.95B 25.75%
2021-03-31 $2.46B $10.80B 23.40%
2020-12-31 $1.97B $10.82B 19.27%
2020-09-30 $1.54B $10.46B 15.49%
2020-06-30 $1.13B $9.90B 11.90%
2020-03-31 $1.16B $9.74B 12.55%
2019-12-31 $1.23B $9.65B 13.81%
2019-09-30 $1.09B $8.84B 12.55%
2019-06-30 $1.08B $8.68B 12.47%
2019-03-31 $1.08B $8.47B 12.45%
2018-12-31 $1.10B $8.70B 12.62%
2018-09-30 $1.15B $8.76B 13.17%
2018-06-30 $1.14B $8.67B 13.17%
2018-03-31 $1.16B $8.78B 13.41%
2017-12-31 $1.17B $8.70B 13.65%
2017-09-30 $1.17B $8.59B 13.86%
2017-06-30 $1.20B $8.47B 14.17%
2017-03-31 $1.30B $8.39B 15.42%
2016-12-31 $1.28B $8.39B 15.15%
2016-09-30 $1.24B $8.51B 14.80%
2016-06-30 $1.55B $8.40B 18.66%
2016-03-31 $1.43B $8.41B 17.46%
2015-12-31 $1.40B $8.21B 17.34%
2015-09-30 $1.42B $8.19B 17.93%
2015-06-30 $1.04B $7.91B 13.29%
2015-03-31 $1.00B $7.96B 12.81%
2014-12-31 $0.98B $7.55B 12.64%
2014-09-30 $1.00B $7.94B 13.00%
2014-06-30 $1.43B $7.86B 19.25%
2014-03-31 $1.46B $7.74B 20.16%
2013-12-31 $1.48B $7.09B 20.69%
2013-09-30 $1.47B $6.99B 20.30%
2013-06-30 $1.09B $7.06B 14.70%
2013-03-31 $1.13B $7.37B 15.12%
2012-12-31 $1.20B $7.54B 16.14%
2012-09-30 $1.25B $7.57B 17.09%
2012-06-30 $1.27B $7.40B 17.73%
2012-03-31 $1.25B $7.26B 17.89%
2011-12-31 $0.99B $7.09B 14.30%
2011-09-30 $0.95B $6.91B 13.99%
2011-06-30 $0.97B $6.78B 14.31%
2011-03-31 $1.02B $6.83B 14.96%
2010-12-31 $1.28B $6.70B 18.88%
2010-09-30 $1.33B $6.72B 19.40%
2010-06-30 $1.34B $6.92B 19.49%
2010-03-31 $1.34B $6.87B 19.59%
2009-12-31 $1.36B $6.95B 20.11%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.063B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.827B 10.78
DaVita (DVA) United States $11.923B 14.81
Encompass Health (EHC) United States $8.608B 22.03
Chemed (CHE) United States $8.132B 25.20
Elanco Animal Health (ELAN) United States $6.597B 17.11
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.632B 96.45
Amedisys (AMED) United States $3.202B 22.68
Astrana Health (ASTH) United States $2.666B 36.05
Addus HomeCare (ADUS) United States $2.179B 28.20
LifeStance Health (LFST) United States $2.095B 0.00
U.S Physical Therapy (USPH) United States $1.424B 38.10
Pennant (PNTG) United States $0.789B 41.67
Aveanna Healthcare Holdings (AVAH) United States $0.677B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00